Navigation Links
Healthcare Holdings Group, Inc. Forecasts Positive Change in EHR Landscape for General Practitioners and Chiropractors
Date:12/10/2012

Boca Raton, FL (PRWEB) December 10, 2012

Healthcare Holdings Group, Inc.'s (HCH) comprehensive Electronic Health Records (EHR) launch at HIMSS13 will raise standards among general practitioners and chiropractic disciplines.

ChartZoneMD EHR Software Suite is ideally suited for practices seeking to replace cumbersome EHR’s, and uniquely positioned for those who are looking to buy new.

“Form, function, and compliance are critical in the choice of EHR software. The combination of those features is hard to find for GP’s, and almost non-existent for DC’s [Doctor Chiropractic]. We introduce flexibility, new technology, and common sense to a significantly restrictive software environment,” said Mr. Lenny Tambasco, CEO of the Company. “We have developed what we consider to be three game-changing software programs for the medical community. With ongoing success in the company’s new EHR Division, we are using a multi-discipline approach for our product debut at HIMSS13. HCH is looking to make a significant impression on the leaders of healthcare technology and the EHR market.”

“Simply put, there are features in the ChartZoneMD Suite that just haven’t been made available to smaller practices or their patients,” said Mr. Greg Roderick, Chief Information Officer and Senior Vice President –EHR Division. “We are on track for MU Certification in Q1 2013. We developed the technology and architecture to the standards of enterprise class without the integration headaches. HIMSS13 attendees will experience our approach to seamless data interaction first-hand. We couldn’t ask to be in a better position.”

About Healthcare Holdings Group, Inc.

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Best Practices, LLC Issues New Report and Webinar on Managing Healthcare Reform through Effective Engagement with the Government Ecosystem
2. Diabetes Research Institute Foundation’s (DRIF) CEO Joins Healthcare Holdings Group, Inc. Board of Directors
3. Palatin Technologies, Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference
4. Neurocrine Biosciences To Present At The 24th Annual Piper Jaffray Healthcare Conference
5. Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference
6. AspenBio to Present at 2012 Lazard Capital Markets Healthcare Conference
7. Palatin Technologies, Inc. To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
8. Cell Therapeutics, Inc. (CTI) to Present at Jefferies 2012 Global Healthcare Conference
9. Regulus to Present at the Lazard Capital Markets Healthcare Conference
10. GNS Healthcare, Dana-Farber and Mount Sinai Collaborate to Build Computer Model of Multiple Myeloma
11. PDL BioPharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... The North American crystal oscillator market report defines ... and forecast of revenue. This market was valued at ... $623.6 million by 2018, at a CAGR of 3.3% ... of the North American crystal oscillator market report, to ... also provides a glimpse of the segmentation of the ...
(Date:10/22/2014)... 2014 Involution Studios , a ... a new infographic, Understanding Ebola . The ... designed, easy to follow informative tool for anyone wanting ... symptoms and prevention. , "As the news has spread ... Ebola outbreak represents not only a healthcare crisis with ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Currently ... Sartorius, A & D Weighing, Rice Lake, and ... Semi-Micro Balance . The Sartorius CPA Semi-Micro Balance ... affordable high-quality, precise, and user-friendly laboratory balance. , ... laboratory equipment, their laboratory balances are well known ...
(Date:10/22/2014)... 2014 Physicians Choice Laboratory Services ... menu, which enables healthcare providers to individualize therapeutic ... evidence-based results, healthcare providers are better able to ... while minimizing risks for adverse drug reactions and ... the FDA [1] more than 2.2 million adverse ...
Breaking Biology Technology:The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 2The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 3The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 4Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3
... ("Phosphagenics") (ASX: POH, AIM: PSG, OTCQX: PPGNY) today,announced ... that showed its,delivery technology, TPM, delivered leading pain-relief ... irritation of any kind., These results support ... a sustained release oxycodone patch for the management ...
... 17 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ; ... a,leading European pharmaceutical and medical devices company, ... Vasogen,s Celacade(TM) System,in Germany. Celacade, a first-in-class ... that specifically targets the destructive chronic,inflammation underlying ...
... SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ) today announced ... Board of Directors. Mr. Turner brings over 25 years ... serve on,the company,s audit committee., "We are delighted ... S.,Henney, Chairman of the Board of Directors of SGX. ...
Cached Biology Technology:Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results 2Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results 3Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure 2Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure 3Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure 4Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure 5SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors 2SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors 3
(Date:10/16/2014)... William and Mary,s Virginia Institute of Marine Science ... Environmental Protection Agency to identify the streams and ... develop tools to help local governments and citizens ... critically on a dataset of tidal-marsh observations first ... with this historical baseline can today,s researchers accurately ...
(Date:10/16/2014)... Calif. (October 16, 2014) – Post-menopausal women experienced ... on hormone levels or genital bleeding, after 12 ... an investigational fermented soy germ-based nutritional supplement previously ... to a new peer-reviewed pilot study reported in ... (NAMS) annual scientific meeting. , "These data ...
(Date:10/15/2014)... German Gauß-Allianz has admitted Johannes Gutenberg University Mainz ... Rhineland-Palatinate science hub continues to maintain a significant ... , "The acceptance of Johannes Gutenberg University ... is a milestone in the national and international ... The state of Rhineland-Palatinate can be proud that ...
Breaking Biology News(10 mins):EPA grant will help localities conserve headwater wetlands 2EPA grant will help localities conserve headwater wetlands 3S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3
... Prostate cancer treatments that target the hormone androgen and its ... a new study. Researchers have found that when two genes ... for the hormone androgen, preventing prostate cells from developing normally. ... Cancer Center, suggests that the gene fusion not the ...
... HOLE, MAMitchell Sogin of the Marine Biological Laboratory (MBL) has ... Torrent of Guilford, Conn., and San Francisco. As ... sequencer, a DNA sequencing system that directly translates chemical signals ... a semiconductor chip. The result is a sequencing system that ...
... Specific dioxins derived from the antibacterial agent triclosan, used ... consumer products, account for an increasing proportion of total ... Minnesota research. The study appears online in the ... and Technology . The researchers, from the university,s ...
Cached Biology News:Gene fusions may be the 'smoking gun' in prostate cancer development, U-M study finds 2MBL scientist awarded next-generation DNA sequencer to monitor water quality 2U of Minn. study finds rising levels of dioxins from common soap ingredient in Mississippi River 2
Anti-rat Dipeptidyl Peptidase IV (DPP IV), CD26, Clone 5E8, Monoclonal Antibody...
... Anti-acetyl-Histone H3 (Lys 4) ... the sequence ...RT[ Ac K]Q... in which ... 4 of human histone H3 ... Molecular Weight: Mr ~17kDa ...
Anti-Mouse Ly 6C.2 , Ascites (Clone 5075-3.6) (mouse IgG2b)...
Goat polyclonal to SIAH Interacting Protein ( Abpromise for all tested applications)....
Biology Products: